Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment
Recruiting
Observational Study
Anterior Cruciate Ligament Injuries
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10 (estimated)
- Sponsor
- Artromedical Konrad Malinowski Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will eva…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with ACL degeneratio mucosa decided to undergo a surgical treatment
* range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI
Exclusion Criteria:
* non-adherence to the study protocol
* active knee inflammation
* range of motion impairm…
Contacts